Clinicopathologic features and prognostic value of claudin 18.2 overexpression in patients with resectable gastric cancer

Claudin 18.2 has emerged as a promising therapeutic target in gastric cancer based on phase 3 studies. However, clinicopathologic features associated with claudin 18.2 overexpression have not been comprehensively studied specifically for patients with resectable gastric cancer. This retrospective st...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyung-Don, Choi, Eugene, Shin, Jinho, Lee, In-Seob, Ko, Chang Seok, Ryu, Min-Hee, Park, Young Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654731/
https://www.ncbi.nlm.nih.gov/pubmed/37973935
http://dx.doi.org/10.1038/s41598-023-47178-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654731/
https://www.ncbi.nlm.nih.gov/pubmed/37973935
http://dx.doi.org/10.1038/s41598-023-47178-6

Ejemplares similares